On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could revolutionize cancer treatment, joining in the global trend as pharmaceutical companies across the world turn to oncology for economic growth and opportunity to make history. As they continue to chase slices of covid vaccine revenue, Pfizer (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA) have already turned to the pursuit of revolutionizing cancer therapies in order to create their new growth chapter in the post-COVID era. Therefore, mRNA technology...